Clinical Trial Update: Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing non-immunogenic recombinant Staphylokinase versus placebo in patients with intermediate-high risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Non-immunogenic recombinant staphylokinase (staphylokinase)

Snippet

Sponsor: Supergene, LLC | Conditions: Pulmonary Embolism | Phase 3 | Status: RECRUITING